Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Диагностика неалкогольной жировой болезни печени в современной клинической практике - Справочник поликлинического врача №3 (2016)
Диагностика неалкогольной жировой болезни печени в современной клинической практике
Е.И.Кузнецова, Д.Н.Андреев. Диагностика неалкогольной жировой болезни печени в современной клинической практике. Справочник поликлинического врача. 2016; 3: 29–32.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtrans Gastrointestinal and liver disease.10th edition. 2015.
2. Mayo Clinic gastroenterology and hepatology board review. Editor-in-chief S.C.Hauser; associate editors A.S.Oxentenko, W.Sanchez. 5th edition. 2015.
3. Маев И.В., Кузнецова Е.И., Андреев Д.Н., Дичева Д.Т. Современные и перспективные подходы к диагностике неалкогольной жировой болезни печени. Consilium Medicum. 2015; 17 (8): 20–7.
4. Park S, Jeon WK, Kim SH et al. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006; 21: 138–43.
5. Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol 2009; 50: 204–10.
6. Hashimoto E, Tokushigie K. Prevalence, gender, ethnic variation, and prognosis of NASH. J Gastroenterol 2011; 46: 63–9.
7. Wong VW, Chu WC, Wong GL et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61 (3): 409–15.
8. Ivashkin V, Drapkina O. The prevalence of non-alcoholic fatty liver disease in Russian Federation. Gut 2009; 58: 1207.
9. Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Неалкогольная жировая болезнь печени: современное состояние проблемы. Мед. вестн. МВД. 2012; 61 (6): 35–40.
10. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 2014; 5 (3): 211–8.
11. Torres DM, Williams CD, Harrison SA. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10: 837–58.
12. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349–62.
13. Маев И.В., Андреев Д.Н. Неалкогольная жировая болезнь печени: механизмы развития, клинические формы и медикаментозная коррекция. Consilium Medicum. Гастроэнтерология (Прил.). 2012; 2: 36–9.
14. Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7 (11): 1450–9.
15. Law K, Brunt EM. Nonalcoholic fatty liver disease. Clin Liver Dis 2010; 14: 591–604.
16. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 5286–96.
17. Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011; 5: 189–200.
18. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–21.
19. Bedossa P, Poitou C, Veyrie N et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012; 56: 1751–9.
20. Богомолов П.О., Павлова Т.В. Неалкогольный стеатогепатит: патофизиология, патоморфология, клиника и подходы к лечению. Фарматека. 2003; 10.
21. Маев И.В., Абдурахманов Д.Т., Андреев Д.Н., Дичева Д.Т. Алкогольная болезнь печени: пособие для врачей. М.: Форте Принт, 2014.
22. Dvorak K, Stritesky J, Petrtyl J et al. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice – an exploratory case-control study. PLoSOne. 2014; 9 (10): e111551.
23. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatology 2013; 58: 1007–19.
24. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–50.
25. Fierbinteanu-Braticevici C, Dina I, Petrisor A et al. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16: 4784–91.
26. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009; 7: 135–40.
27. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–13.
28. Bonder A, Afdhal N. Utilization of Fibro Scan in clinical practice. Curr Gastroenterol Rep 2014; 16 (2): 372.
29. Carey E, Carey WD. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleve Clin J Med 2010; 77 (8): 519–27.
30. Ebinuma H, Saito H, Komuta M et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FibroScan®. J Gastroenterol 2011; 46: 1238–48.
31. Rustogi R, Horowitz J, Harmath C et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012; 35: 1356–64.
2. Mayo Clinic gastroenterology and hepatology board review. Editor-in-chief S.C.Hauser; associate editors A.S.Oxentenko, W.Sanchez. 5th edition. 2015.
3. Маев И.В., Кузнецова Е.И., Андреев Д.Н., Дичева Д.Т. Современные и перспективные подходы к диагностике неалкогольной жировой болезни печени. Consilium Medicum. 2015; 17 (8): 20–7.
4. Park S, Jeon WK, Kim SH et al. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006; 21: 138–43.
5. Fan JG, Farrell GC. Epidemiology of nonalcoholic fatty liver disease in China. J Hepatol 2009; 50: 204–10.
6. Hashimoto E, Tokushigie K. Prevalence, gender, ethnic variation, and prognosis of NASH. J Gastroenterol 2011; 46: 63–9.
7. Wong VW, Chu WC, Wong GL et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61 (3): 409–15.
8. Ivashkin V, Drapkina O. The prevalence of non-alcoholic fatty liver disease in Russian Federation. Gut 2009; 58: 1207.
9. Маев И.В., Андреев Д.Н., Дичева Д.Т. и др. Неалкогольная жировая болезнь печени: современное состояние проблемы. Мед. вестн. МВД. 2012; 61 (6): 35–40.
10. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 2014; 5 (3): 211–8.
11. Torres DM, Williams CD, Harrison SA. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10: 837–58.
12. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis 2004; 24: 349–62.
13. Маев И.В., Андреев Д.Н. Неалкогольная жировая болезнь печени: механизмы развития, клинические формы и медикаментозная коррекция. Consilium Medicum. Гастроэнтерология (Прил.). 2012; 2: 36–9.
14. Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7 (11): 1450–9.
15. Law K, Brunt EM. Nonalcoholic fatty liver disease. Clin Liver Dis 2010; 14: 591–604.
16. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 5286–96.
17. Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011; 5: 189–200.
18. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313–21.
19. Bedossa P, Poitou C, Veyrie N et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012; 56: 1751–9.
20. Богомолов П.О., Павлова Т.В. Неалкогольный стеатогепатит: патофизиология, патоморфология, клиника и подходы к лечению. Фарматека. 2003; 10.
21. Маев И.В., Абдурахманов Д.Т., Андреев Д.Н., Дичева Д.Т. Алкогольная болезнь печени: пособие для врачей. М.: Форте Принт, 2014.
22. Dvorak K, Stritesky J, Petrtyl J et al. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice – an exploratory case-control study. PLoSOne. 2014; 9 (10): e111551.
23. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J Hepatology 2013; 58: 1007–19.
24. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–50.
25. Fierbinteanu-Braticevici C, Dina I, Petrisor A et al. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16: 4784–91.
26. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009; 7: 135–40.
27. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–13.
28. Bonder A, Afdhal N. Utilization of Fibro Scan in clinical practice. Curr Gastroenterol Rep 2014; 16 (2): 372.
29. Carey E, Carey WD. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleve Clin J Med 2010; 77 (8): 519–27.
30. Ebinuma H, Saito H, Komuta M et al. Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with FibroScan®. J Gastroenterol 2011; 46: 1238–48.
31. Rustogi R, Horowitz J, Harmath C et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 2012; 35: 1356–64.
Авторы
Е.И.Кузнецова, Д.Н.Андреев
ГБОУ ВПО Московский государственный медико-стоматологический университет им. А.И.Евдокимова Минздрава России
ГБОУ ВПО Московский государственный медико-стоматологический университет им. А.И.Евдокимова Минздрава России
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.